Anti-CD1B monoclonal antibody, clone 20.27

Two mAbs, CC43 (012) and CC118 (040), clustered together when the flow cytometric data for staining of target cells was analysed statistically. The antigen recognized was present on immature thymocytes but not mature T cells; it was expressed by B cells and monocytes but not by granulocytes. Two molecules were evident by SDS-PAGE run under reducing conditions. One had an M(r) of 44 kDa, the other an M(r) of 12 kDa. The smaller molecule was probably beta2-microglobulin; the larger one was distinct from bovine CD1b and MHC Class I. The mAb may recognize the product of a previously unrecognized bovine CD1 gene and should be considered as a novel bovine mAb cluster. The molecule appeared to be polymorphic and distinct alleles may be expressed on Bos taurus and Bos indicus.

We have compared the immune responses of mice immunized either with alpha-galactosylceramide (alpha-GalCer), capable of eliciting a CD1-metiated stimulation of V alpha 14(+) NK T cells, or with lipoarabinomannan (LAM), a glycophospholipid derived from mycobacteria which is known to be presented by CD1b in humans. Within 24 h, alpha-GalCer induces a burst of IFN-gamma secretion in vivo, and recall with antigen in vitro leads to the synthesis of IL-4 and IL-10 in addition to IFN-gamma. Associated with this in vivo cytokine release is a polyclonal activation of splenic B and T cells. CD1-reactive NK T lymphocytes mediate these events, because none of them are observed in alpha-GalCer-immunized CD1(-/-) mice. LAM immunization fails to promote similar early responses in vivo. Repeated exposure of mice to alpha-GalCer induces splenic T cells to secrete IL-4 and IL-10 but dramatically reduced levels of IFN-gamma. Such a bias in the cytokine balance triggered by NK T cells stimulated with multiple doses of alpha-GalCer suggests that this compound might be useful in the induction of Th2 immune responses and the prevention of chronic inflammatory conditions mediated by Th1 cytokines.